MedTrace Logo

Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer

NCT04087057 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2024-04-22

No results posted yet for this study

Summary

This trial studies the barriers associated with timely chemotherapy given after surgery (adjuvant) in patients with invasive breast cancer. Meeting with patients and asking questions may help doctors to learn about factors that can cause delays in the start of chemotherapy after surgery in patients with breast cancer.

Conditions

  • Invasive Breast Carcinoma

Interventions

OTHER

Interview

Participate in interview

OTHER

Medical Chart Review

Patients' medical records are reviewed

BEHAVIORAL

Questionnaire

Complete questionnaires

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Mariana Chavez Mac Gregor · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-23
Primary Completion
2024-04-16
Completion
2024-04-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04087057 on ClinicalTrials.gov